查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1720536

前列腺肥大症手術的全球市場 - 市場規模，佔有率，趨勢，產業分析:各類型，各終端用戶，各地區 - 市場預測(2025年～2034年)

Benign Prostatic Hyperplasia Surgical Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, End User, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2034 年，全球良性攝護腺增生手術市場規模將達到 211.9 億美元。

良性攝護腺增生 (BPH) 手術市場專注於治療良性攝護腺增生此常見疾病，通常會導致頻尿、尿滯留和膀胱炎等症狀。當藥物治療等保守治療無法緩解症狀時，就需要進行 BPH 手術。由於 BPH 盛行率的不斷上升，尤其是在更容易罹患良性前列腺增生的老年男性中，BPH 手術市場呈現顯著成長。對雷射治療、經尿道前列腺電切術 (TURP) 和前列腺動脈栓塞術 (PAE) 等微創手術的需求日益增長，這極大地促進了良性前列腺增生手術市場的擴張。

能夠改善患者預後（例如縮短復原時間、減少併發症和縮短住院時間）的手術技術的開發是市場成長的主要驅動力之一。此外，對良性前列腺增生 (BPH) 的認識和診斷水平的提高、醫療保健可及性的提高以及報銷政策的完善也推動了市場需求。機器人輔助手術的引入和雷射手術的日益普及正在改變治療格局，為患者提供更多選擇，從而推動整個良性前列腺增生手術市場的成長。

市場動態也包括對門診手術的日益偏好，這刺激了手術技術的創新。此外，一些地區可支配收入的增加也擴大了獲得先進治療的機會。人口老化和對以患者為中心的解決方案的日益關注為市場擴張提供了充足的機會。預計市場研發活動也將增加，以進一步優化治療方案並推動基於價值的醫療保健。因此，市場預計將持續發展，為醫療保健行業的利益相關者提供充滿希望的機會。

良性攝護腺增生 (BPH) 手術市場報告重點

按類型劃分，雷射手術憑藉其精準度、微創性和短恢復時間，在 2024 年佔據了顯著的市場佔有率。

按最終用戶劃分，家庭醫療保健在 2024 年佔據了最大的市場佔有率，這得益於患者越來越傾向於便捷且經濟高效的治療方案。

2024 年，由於 BPH 的高發病率和先進的醫療基礎設施，北美佔據了最大的市場佔有率。

由於醫療保健可近性的提高和老年人口的增加，預計亞太地區的 BPH 治療市場在預測期內將成長最快。

全球市場的主要參與者包括Allium，Alembic Pharmaceuticals Limited，Asahi Kasei Corporation，Asclepion Laser Technologies GmbH，Boston Scientific Corporation，Coloplast Group，Cook Medical，IPG Photonics Corporation，Karl Storz Se & Co.KG，Medifocus, Inc，Olympus Corporation，PNN Medical A/S，ProstaLund Ab，PROCEPT BioRobotics Corporation，Quanta System，Richard Wolf GmbH，SRS Medical，Teleflex Incorporated，Urologix, LLC.等。

本報告提供全球前列腺肥大症手術市場相關調查，目前市場動態的詳細的考察，及未來市場成長相關分析。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球前列腺肥大症手術市場考察

  • 市場概況
  • BPH 手術市場動態
    • 驅動因素與機遇
      • 微創手術的普及率不斷提高
      • 老年人口不斷增加
    • 限制與挑戰
      • 手術費用高昂
  • PESTEL分析
  • 前列腺肥大症手術市場用途趨勢
  • 價值鏈分析

第5章 全球前列腺肥大症手術市場:各類型

  • 主要發現
  • 簡介
  • 經尿道攝護腺切除術 (TURP)
  • 雷射手術
  • UroLift 手術
  • Rezum 手術
  • 機器人輔助水刀消融術
  • 攝護腺支架
  • 經尿道微波熱療 (TUMT)
  • 經尿道攝護腺針棘消融術 (TUNA)
  • 攝護腺動脈栓塞術 (PAE)
  • 其他手術

第6章 全球前列腺肥大症手術市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 醫院
  • 門診病人手術中心，診療所
  • 居家醫療

第7章 全球前列腺肥大症手術市場:各地區

  • 主要調查結果
  • 簡介
    • 前列腺肥大症手術市場分析:各地區(2020年～2034年)
  • 北美
    • 北美:各類型(2020年～2034年)
    • 北美:各終端用戶(2020年～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各類型(2020年～2034年)
    • 歐洲:各終端用戶(2020年～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他的歐洲
  • 亞太地區
    • 亞太地區:各類型(2020年～2034年)
    • 亞太地區:各終端用戶(2020年～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他的亞太地區
  • 中東·非洲
    • 中東·非洲:各類型(2020年～2034年)
    • 中東·非洲:各終端用戶(2020年～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他的中東·非洲
  • 南美
    • 南美:各類型(2020年～2034年)
    • 南美:各終端用戶(2020年～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他的南美

第8章 競爭情形

  • 擴張和收購的分析
    • 擴大
    • 收購
  • 夥伴關係/合作/協定/公開

第9章 企業簡介

  • Allium
  • Alembic Pharmaceuticals Limited
  • Asahi Kasei Corporation
  • Asclepion Laser Technologies GmbH
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • IPG Photonics Corporation
  • Karl Storz Se & Co. KG
  • Medifocus, Inc.
  • Olympus Corporation
  • PNN Medical A/S
  • ProstaLund Ab
  • PROCEPT BioRobotics Corporatio
  • Quanta System
  • Richard Wolf GmbH
  • SRS Medical
  • Teleflex Incorporated
  • Urologix, LLC
Product Code: PM5490

The global benign prostatic hyperplasia surgical treatment market size is expected to reach USD 21.19 billion by 2034, according to a new study by Polaris Market Research. The report "Benign Prostatic Hyperplasia Surgical Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, End User (Hospitals, Ambulatory Surgery Centers and Clinics, and Homecare Settings), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The benign prostatic hyperplasia (BPH) surgical treatment market focuses on addressing the medical condition of an enlarged prostate, which often leads to symptoms such as frequent urination, urinary retention, and bladder infections. Surgical treatments for BPH are necessary when conservative therapies like medications fail to alleviate symptoms. The market has seen notable growth, driven by an increasing incidence of BPH, especially among the aging male population, who are more susceptible to prostate enlargement. The rising demand for minimally invasive procedures, such as laser-based therapies, transurethral resection of the prostate (TURP), and prostate artery embolization (PAE), is significantly contributing to the benign prostatic hyperplasia surgical treatment market expansion.

Advancements in surgical technology, which offer improved patient outcomes with shorter recovery times, reduced complications, and minimal hospital stays, is one of the key factors fueling market development. Moreover, rising awareness and diagnosis of BPH, coupled with increased healthcare access and reimbursement policies, have propelled market demand. The introduction of robotic-assisted surgeries and the growing adoption of laser surgeries are transforming the treatment landscape, providing patients with more options and driving the overall benign prostatic hyperplasia surgical treatment market growth.

The market dynamics also include a growing preference for outpatient procedures, which has spurred innovation in surgical techniques. Additionally, rising disposable income in several regions is enabling greater access to advanced treatments. The market holds considerable opportunity for expansion as the population continues to age, with an increasing focus on patient-centric solutions. The market is also poised to witness more research and development efforts, further optimizing treatment options and promoting value-based care. Consequently, the market is expected to continue evolving, presenting promising opportunities for stakeholders involved in the healthcare industry.

Benign Prostatic Hyperplasia Surgical Treatment Market Report Highlights

In terms of type, the laser surgeries segment accounted for a significant market share in 2024 due to their precision, minimal invasiveness, and shorter recovery time.

Based on end user, the homecare settings segment accounted for the largest market share in 2024 due to growing patient preference for convenience and cost-effective treatment options.

In 2024, North America accounted for the largest market share due to the high prevalence of BPH and advanced healthcare infrastructure.

The Asia Pacific benign prostatic hyperplasia surgical treatment market is expected to witness the fastest growth during the forecast period due to increasing healthcare access and a rising elderly population.

Some of the global key market players are Allium; Alembic Pharmaceuticals Limited; Asahi Kasei Corporation; Asclepion Laser Technologies GmbH; Boston Scientific Corporation; Coloplast Group; Cook Medical; IPG Photonics Corporation; Karl Storz Se & Co. KG; Medifocus, Inc.; Olympus Corporation; PNN Medical A/S; ProstaLund Ab; PROCEPT BioRobotics Corporation; Quanta System; Richard Wolf GmbH; SRS Medical; Teleflex Incorporated; and Urologix, LLC.

Polaris Market Research has segmented the benign prostatic hyperplasia surgical treatment market report on the basis of type, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

  • Transurethral Resection of the Prostate (TURP)
  • Laser Surgeries
  • Urolift Procedures
  • Rezum Procedures
  • Robot-Assisted Waterjet Ablation
  • Prostatic Stents
  • Transurethral Microwave Thermotherapy (TUMT)
  • Transurethral Needle Ablation of the Prostate (TUNA)
  • Prostatic Arterial Embolization (PAE)
  • Other Procedures

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Hospitals
  • Ambulatory Surgery Centers and Clinics
  • Homecare Settings

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Benign Prostatic Hyperplasia Surgical Treatment Market Insights

  • 4.1. Benign Prostatic Hyperplasia Surgical Treatment Market - Market Snapshot
  • 4.2. Benign Prostatic Hyperplasia Surgical Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Adoption of Minimally Invasive Procedures
      • 4.2.1.2. Expanding Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs of Surgery
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Benign Prostatic Hyperplasia Surgical Treatment Market Application Trends
  • 4.6. Value Chain Analysis

5. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Transurethral Resection of the Prostate (TURP)
    • 5.3.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Resection of the Prostate (TURP), by Region, 2020-2034 (USD Billion)
  • 5.4. Laser Surgeries
    • 5.4.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Laser Surgeries, by Region, 2020-2034 (USD Billion)
  • 5.5. Urolift Procedures
    • 5.5.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Urolift Procedures, by Region, 2020-2034 (USD Billion)
  • 5.6. Rezum Procedures
    • 5.6.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Rezum Procedures, by Region, 2020-2034 (USD Billion)
  • 5.7. Robot-Assisted Waterjet Ablation
    • 5.7.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, Robot-Assisted Waterjet Ablation, by Region, 2020-2034 (USD Billion)
  • 5.8. Prostatic Stents
    • 5.8.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Prostatic Stents, by Region, 2020-2034 (USD Billion)
  • 5.9. Transurethral Microwave Thermotherapy (TUMT)
    • 5.9.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Microwave Thermotherapy (TUMT), by Region, 2020-2034 (USD Billion)
  • 5.10. Transurethral Needle Ablation of the Prostate (TUNA)
    • 5.10.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Needle Ablation of the Prostate (TUNA), by Region, 2020-2034 (USD Billion)
  • 5.11. Prostatic Arterial Embolization (PAE)
    • 5.11.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Prostatic Arterial Embolization (PAE), by Region, 2020-2034 (USD Billion)
  • 5.12. Other Procedures
    • 5.12.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Other Procedures, by Region, 2020-2034 (USD Billion)

6. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 6.4. Ambulatory Surgery Centers and Clinics
    • 6.4.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Ambulatory Surgery Centers and Clinics, by Region, 2020-2034 (USD Billion)
  • 6.5. Homecare Settings
    • 6.5.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Homecare Settings, by Region, 2020-2034 (USD Billion)

7. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Benign Prostatic Hyperplasia Surgical Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Benign Prostatic Hyperplasia Surgical Treatment Market - North America
    • 7.3.1. North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.3.2. North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.3.3. Benign Prostatic Hyperplasia Surgical Treatment Market - U.S.
      • 7.3.3.1. U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.3.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Canada
      • 7.3.4.1. Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Europe
    • 7.4.1. Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.3. Benign Prostatic Hyperplasia Surgical Treatment Market - UK
      • 7.4.3.1. UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.4. Benign Prostatic Hyperplasia Surgical Treatment Market - France
      • 7.4.4.1. France: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Germany
      • 7.4.5.1. Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Italy
      • 7.4.6.1. Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Spain
      • 7.4.7.1. Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.8. Benign Prostatic Hyperplasia Surgical Treatment Market - Netherlands
      • 7.4.8.1. Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.9. Benign Prostatic Hyperplasia Surgical Treatment Market - Russia
      • 7.4.9.1. Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.10. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Asia Pacific
    • 7.5.1. Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.3. Benign Prostatic Hyperplasia Surgical Treatment Market - China
      • 7.5.3.1. China: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.4. Benign Prostatic Hyperplasia Surgical Treatment Market - India
      • 7.5.4.1. India: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Malaysia
      • 7.5.5.1. Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Japan
      • 7.5.6.1. Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Indonesia
      • 7.5.7.1. Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.8. Benign Prostatic Hyperplasia Surgical Treatment Market - South Korea
      • 7.5.8.1. South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.9. Benign Prostatic Hyperplasia Surgical Treatment Market - Australia
      • 7.5.9.1. Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.10. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.3. Benign Prostatic Hyperplasia Surgical Treatment Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.4. Benign Prostatic Hyperplasia Surgical Treatment Market - UAE
      • 7.6.4.1. UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Israel
      • 7.6.5.1. Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.6. Benign Prostatic Hyperplasia Surgical Treatment Market - South Africa
      • 7.6.6.1. South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Latin America
    • 7.7.1. Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.3. Benign Prostatic Hyperplasia Surgical Treatment Market - Mexico
      • 7.7.3.1. Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Brazil
      • 7.7.4.1. Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Argentina
      • 7.7.5.1. Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Allium
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Alembic Pharmaceuticals Limited
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Asahi Kasei Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Asclepion Laser Technologies GmbH
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Boston Scientific Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Coloplast Group
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Cook Medical
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. IPG Photonics Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Karl Storz Se & Co. KG
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Medifocus, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Olympus Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. PNN Medical A/S
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. ProstaLund Ab
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. PROCEPT BioRobotics Corporatio
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Quanta System
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. Richard Wolf GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
  • 9.17. SRS Medical
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Development
  • 9.18. Teleflex Incorporated
    • 9.18.1. Company Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Recent Development
  • 9.19. Urologix, LLC
    • 9.19.1. Company Overview
    • 9.19.2. Financial Performance
    • 9.19.3. Product Benchmarking
    • 9.19.4. Recent Development

List of Tables:

  • Table 1 Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 3 North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 4 North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 5 U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 6 U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 7 Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 8 Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 9 Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 10 Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 11 UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 12 UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 13 France: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 14 France: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 15 Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 16 Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 17 Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 19 Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 20 Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 23 Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 24 Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 29 China: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 30 China: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 31 India: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 32 India: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 35 Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 36 Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 39 South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 40 South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 41 Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 49 UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 50 UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 51 Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 53 South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 54 South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 57 Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 58 Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 59 Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 60 Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 63 Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 64 Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by End User
  • Figure 9. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2024 & 2034 (USD Billion)